Biotech improves cranial surgery

An innovative hybrid plate for cranial defects treatment has been developed in Russia. The solution comes from a research team at Moscow-based MISiS University.

The plate is reported to show a considerably higher level of bioactivity than any other analog that currently exists – an achievement that the team says ensures an implant’s good integration into the bone tissue with a minimum possible risk of rejection. The solution may be applied in neural surgery and trauma treatment.

The new plate has been tested and its biocompatibility proven.

Source